Effects of iontophoresis and chemical enhancers on the transport of lidocaine and nicotine across the oral mucosa

Pharmaceutical Research

Volumn 29, Issue 4, 2012, Pages 961-971

  Wei, Ran ^a   Simon, Laurent ^a   Hu, Longsheng ^b   Michniak Kohn, Bozena ^b  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Chemical enhancer; Iontophoresis; Oral mucosa

Indexed keywords

DODECYL 2 (N,N DIMETHYLAMINO)PROPIONATE; LAUROCAPRAM; LIDOCAINE; NICOTINE TARTRATE; PROPIONIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; IONTOPHORESIS; MOUTH MUCOSA; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REACTION TIME; SWINE;

ADMINISTRATION, BUCCAL; ANIMALS; BIOLOGICAL TRANSPORT; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; DRUG DELIVERY SYSTEMS; GELS; IONTOPHORESIS; LIDOCAINE; MOUTH MUCOSA; NICOTINE; SWINE;

EID: 84862699681     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0636-x     Document Type: Article

References (28)

1. Smith DW, Peterson MR, DeBerard SC. Regional anesthesia: nerve blocks ofthe extremities and face. Postgrad Med. 1999;106 (4):69-73. 77-78.
2. Pfeifer HJ, Greenblatt DJ, Koch-Weser J. Clinical use and toxicity of intravenous lidocaine: a report from the Boston Collaborative Drug Surveillance Program. Am Heart J. 1976;92(2):168-73.
3. Lee PJ, Ahmad N, Langer R, Mitragotri S, Prasad Shastri V. Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm. 2006;308(1-2):33-9.
4. Varshosaz J, Karimzadeh S. Development of cross-linked chitosan films for oral mucosal delivery of lidocaine. Res Pharm Sci. 2007;2(1):43-52.
5. Gorsline J, Gupta SK, Dye D, Rolf CN. Steady-state pharmacokinetics and dose relationship of nicotine delivered from Nicoderm® (Nicotine Transdermal System). J Clin Pharmacol. 1993;33(2):161-8.
6. Sangeetha S, Venkatesh DN, Krishan PN, Saraswathi R. Mucosa as a route for systemic drug delivery. Res J Pharm Biol Chem Sci. 2010;1(3):178-87.
7. Perry DA, Gansky SA, Loomer PM. Effectiveness of a transmucosal lidocaine delivery system for local anaesthesia during scaling and root planning. J Clin Periodontol. 2005;32(6):590-4.
8. Muramoto ML, Ranger-Moore J, Leischow SJ. Efficacy of oral transmucosal nicotine lozenge for suppression of withdrawal symptoms in smoking abstinence. Nicotine Tob Res. 2003;5 (2):223-30.
9. Hassan N, Ahad A, Ali M, Ali J. Chemical permeation enhancers for transbuccal drug delivery. Expert Opin Drug Del. 2010;7 (1):97-112.
10. Pathan IB, Setty CM. Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res. 2009;8 (2):173-9.
11. Dixit N, Bali V, Baboota S, Ahuja A, Ali J. Iontophoresis - an approach for controlled drug delivery: a review. Curr Drug Deliv. 2007;4(1):1-10.
12. Nolan LMA, Corish J, Corrigan OI, Fitzpatrick D. Combined effects of iontophoretic and chemical enhancement on drug delivery II. Transport across human and murine skin. Int J Pharm. 2007;341(1-2):114-24.
13. Brand RM, Guy RH. Iontophoresis of nicotine in vitro: pulsatile drug delivery across the skin? J Contr Release. 1995;33(2):285-92.
14. Jacobsen B. Buccal iontophoretic delivery of atenolol·HCl employing a new in vitro three-chamber permeation cell. J Contr Release. 2001;70(1-2):83-95.
15. Giannola LI, De Caro V, Giandalia G, Siragusa MG, Campisi G, Florena AM, Ciach T. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. Eur J Pharm Biopharm. 2007;65(2):238-46.
16. Giannola LI, De Caro V, Giandalia G, Siragusa MG, Tripodo C, Florena AM, Campisi G. Release of naltrexone on buccal mucosa: permeation studies, histological aspects and matrix system design. Eur J Pharm Biopharm. 2007;67(2):425-33.
17. Simon L. Timely drug delivery from controlled-release devices: dynamic analysis and novel design concepts. Math Biosci. 2009;217(2):151-8.
18. Collins R. The choice of an effective time constant for diffusive processes in finite systems. J Phys D Appl Phys. 1980;13 (11):1935-47.
19. Crank J. The mathematics of diffusion. 2nd ed. Oxford: Clarendon; 1975.
20. Keister JC, Kasting GB. Ionic mass transport through a homogeneous membrane in the presence of an electric field. J Membr Sci. 1986;29(2):155-67.
21. Simon L, Weltner A, Wang Y, Michniak B. A parametric study of iontophoretic transdermal drug delivery systems. J Membr Sci. 2006;278(1-2):124-32.
22. Büyüktimkin S, Büyüktimkin N, Rytting JH. Synthesis and enhancing effect of dodecyl 2-(N, N-dimethylamino) propionate (DDAIP) on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone. Pharm Res. 1993;10(11):1632-7.
23. Song Y, Xiao C, Mendelsohn R, Zheng T, Strekowski L, Michniak B. Investigation of iminosulfuranes as novel transdermal penetration enhancers: enhancement activity and cytotoxicity. Pharm Res. 2005;22(11):1918-25.
24. Hu L. Transdermal and transbuccal drug delivery enhancement using iontophoresis and chemical enhancers. Ph.D. Dissertation, New Brunswick, New Jersey: Rutgers University; 2010.
25. Hu L, Silva SM, Damaj BB, Martin R, Michniak-Kohn BB. Transdermal and transbuccal drug delivery systems: Enhancement using iontophoretic and chemical approaches. Int J Pharm. 2011 Sep 22. [Epub ahead of print].
26. Nicolazzo JA, Reed BL, Finnin BC. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Contr Release. 2005;105(3):240-8.
27. Tojo K. Mathematical models of transdermal and topical drug delivery. Fukuoka, Japan: Biocom Systems; 2003.
28. Wearly LL. Iontophoresis-facilitated transdermal delivery of verapamil. II. Factors affecting the reversibility of skin permeability. J Contr Release. 1989;9(3):231-42.